AbbVie, Inc. (ABBV)
254.49
+0.10
(+0.04%)
USD |
NYSE |
Jul 17, 16:00
254.35
-0.14
(-0.06%)
After-Hours: 20:00
AbbVie Price : 254.49 for July 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 17, 2026 | 257.00 | 260.96 | 254.29 | 254.49 | 6.873M |
| Jul 16, 2026 | 244.75 | 254.54 | 243.50 | 254.39 | 6.555M |
| Jul 15, 2026 | 243.32 | 247.75 | 243.07 | 244.11 | 6.389M |
| Jul 14, 2026 | 245.99 | 246.42 | 243.19 | 244.78 | 5.247M |
| Jul 13, 2026 | 248.37 | 249.74 | 244.61 | 248.00 | 4.156M |
| Jul 10, 2026 | 251.00 | 251.66 | 245.05 | 248.08 | 5.781M |
| Jul 09, 2026 | 251.20 | 254.86 | 247.99 | 249.91 | 5.526M |
| Jul 08, 2026 | 253.25 | 255.82 | 250.70 | 252.74 | 7.579M |
| Jul 07, 2026 | 257.21 | 260.35 | 254.27 | 254.65 | 8.238M |
| Jul 06, 2026 | 259.92 | 260.92 | 253.60 | 254.76 | 8.580M |
| Jul 02, 2026 | 252.30 | 261.64 | 250.51 | 261.07 | 7.114M |
| Jul 01, 2026 | 250.75 | 251.80 | 247.56 | 251.06 | 6.988M |
| Jun 30, 2026 | 255.00 | 255.50 | 250.10 | 251.64 | 7.000M |
| Jun 29, 2026 | 253.05 | 255.99 | 249.20 | 254.31 | 9.761M |
| Jun 26, 2026 | 245.26 | 253.35 | 244.66 | 253.35 | 52.64M |
| Jun 25, 2026 | 233.66 | 244.61 | 233.66 | 243.14 | 10.28M |
| Jun 24, 2026 | 236.35 | 237.36 | 232.85 | 234.89 | 7.311M |
| Jun 23, 2026 | 232.97 | 235.31 | 231.30 | 234.76 | 7.366M |
| Jun 22, 2026 | 221.94 | 232.32 | 221.94 | 230.01 | 9.913M |
| Jun 18, 2026 | 221.37 | 222.35 | 215.37 | 216.49 | 9.646M |
| Jun 17, 2026 | 222.40 | 222.84 | 218.83 | 221.23 | 5.624M |
| Jun 16, 2026 | 223.31 | 223.50 | 219.15 | 222.47 | 5.946M |
| Jun 15, 2026 | 226.00 | 226.50 | 220.00 | 221.59 | 5.262M |
| Jun 12, 2026 | 227.50 | 228.40 | 224.32 | 227.73 | 4.087M |
| Jun 11, 2026 | 226.01 | 227.55 | 224.04 | 224.77 | 4.569M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 205.99 |
| Gilead Sciences, Inc. | 134.28 |
| Regeneron Pharmaceuticals, Inc. | 676.69 |
| Travere Therapeutics, Inc. | 56.71 |
| Amgen, Inc. | 366.29 |
Price Related Metrics
| PE Ratio | 125.53 |
| PS Ratio | 7.182 |
| Price to Free Cash Flow | 22.58 |
| Earnings Yield | 0.80% |
| Market Cap | 449.62B |
| Operating PE Ratio | 21.39 |
| Normalized PE Ratio | 34.77 |